These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2621567)

  • 1. [Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation: evaluation for sublingual and oral administrations in humans].
    Seo H; Uekama K
    Yakugaku Zasshi; 1989 Oct; 109(10):778-82. PubMed ID: 2621567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced bioavailability of digoxin by gamma-cyclodextrin complexation.
    Uekama K; Fujinaga T; Otagiri M; Seo H; Tsuruoka M
    J Pharmacobiodyn; 1981 Sep; 4(9):735-7. PubMed ID: 7334457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of 2-hydroxypropyl-beta-cyclodextrin on pharmacokinetics of digoxin in rabbits and humans.
    He ZG; Li YS; Zhang TH; Tang X; Zhao C; Zhang RH
    Pharmazie; 2004 Mar; 59(3):200-2. PubMed ID: 15074593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cyclodextrins on the acid hydrolysis of digoxin.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Kurono Y; Ikeda K
    J Pharm Pharmacol; 1982 Oct; 34(10):627-30. PubMed ID: 6128384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the oral bioavailability of digitalis glycosides by cyclodextrin complexation.
    Uekama K; Fujinaga T; Hirayama F; Otagiri M; Yamasaki M; Seo H; Hashimoto T; Tsuruoka M
    J Pharm Sci; 1983 Nov; 72(11):1338-41. PubMed ID: 6644599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of bio(in)equivalence of deriphyllin-digoxin in human volunteers. II. Evaluation of rabbits as qualitative animal model.
    Bansinath M; Ghosh SS; Shukla VK; Chopra KS; Mathur VS
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):303-7. PubMed ID: 3724304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-beta-cyclodextrin complexation in healthy volunteers.
    Panini R; Vandelli MA; Forni F; Pradelli JM; Salvioli G
    Pharmacol Res; 1995; 31(3-4):205-9. PubMed ID: 7630860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of particle size on the bioavailability of digoxin.
    Jounela AJ; Pentikäinen PJ; Sothmann A
    Eur J Clin Pharmacol; 1975 Jun; 8(5):365-70. PubMed ID: 1233237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of digoxin-hydroquinone complex: a new oral digoxin formulation.
    Bochner F; Huffman DH; Shen DD; Azarnoff DL
    J Pharm Sci; 1977 May; 66(5):644-7. PubMed ID: 874745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of antiinflammatory drug flurbiprofen in rabbits by tri-O-methyl-beta-cyclodextrin complexation.
    Otagiri M; Imai T; Uekama K
    J Pharmacobiodyn; 1982 Dec; 5(12):1027-9. PubMed ID: 7169606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of oral bioavailability of prednisolone by beta-cyclodextrin complexation in humans.
    Uekama K; Otagiri M; Uemura Y; Fujinaga T; Arimori K; Matsuo N; Tasaki K; Sugii A
    J Pharmacobiodyn; 1983 Feb; 6(2):124-7. PubMed ID: 6864436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior bioavailability of digoxin solution in capsules.
    Mallis GI; Schmidt DH; Lindenbaum J
    Clin Pharmacol Ther; 1975 Dec; 18(6):761-8. PubMed ID: 1106935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
    Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
    Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
    Mannila J; Järvinen T; Järvinen K; Tarvainen M; Jarho P
    Eur J Pharm Sci; 2005 Sep; 26(1):71-7. PubMed ID: 15955678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The formation of an inclusion complex between a metabolite of ginsenoside, compound K and γ-cyclodextrin and its dissolution characteristics.
    Igami K; Ozawa M; Inoue S; Iohara D; Miyazaki T; Shinoda M; Anraku M; Hirayama F; Uekama K
    J Pharm Pharmacol; 2016 May; 68(5):646-54. PubMed ID: 26255976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent bioavailability from digoxin elixir and rapid-dissolution tablets.
    Greenblatt DJ; Duhme DW; Koch-Weser J; Smith TW
    JAMA; 1974 Sep; 229(13):1774-6. PubMed ID: 4479121
    [No Abstract]   [Full Text] [Related]  

  • 19. Formulation and Characterization of Fast-Dissolving Sublingual Film of Iloperidone Using Box-Behnken Design for Enhancement of Oral Bioavailability.
    Londhe V; Shirsat R
    AAPS PharmSciTech; 2018 Apr; 19(3):1392-1400. PubMed ID: 29396734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Precipitation complexation method produces cannabidiol/beta-cyclodextrin inclusion complex suitable for sublingual administration of cannabidiol.
    Mannila J; Järvinen T; Järvinen K; Jarho P
    J Pharm Sci; 2007 Feb; 96(2):312-9. PubMed ID: 17051591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.